Vascular endothelial growth factor expressing mesenchymal stem cells improves cardiac function in chronic myocardial infarction in pigs
摘要篇首: Transplantation of mesenchymal stem cells (MSCs) for myocardial reconstruction has shown promise in both animal models and human phase 1 clinical studies.1,2 Vascular endothelial growth factor (VEGF) is a strong therapeutic agent for treating ischaemia by inducing angiogenesis.3 The feasibility of ex vivo MSCs mediated gene transfer is documented.
更多相关知识
- 浏览148
- 被引13
- 下载0

相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文